Overview

• Across party lines, federal deputies criticized symbolic pink gestures and urged more resources, with one citing a MXN 2,233 million allocation to the National Cancer Institute as insufficient and others noting past MXN 150 million cuts and an estimated 22 daily deaths.
• Regional health agencies report a heavy burden, with Latin America and the Caribbean logging over 210,000 new cases and nearly 68,000 deaths in 2020, while Mexico records more than 23,000 diagnoses and about 8,000 deaths each year.
• Clinicians highlight barriers to timely care, including limited mammography access, costly advanced diagnostics, rural gaps and language hurdles, with treatment starts sometimes delayed six to eight months versus the WHO’s 60‑day target.
• Local screening efforts intensified, including free mammograms in Mexico City’s Venustiano Carranza on October 7 and October 14 and walk‑in access at three public centers in Lomas de Zamora, Argentina.
• New Mexican data shared via ASCO on 1,673 patients using Mammaprint showed 61% at low metastatic risk who avoided chemotherapy, reinforcing the case for genomic profiling even as coverage and access remain uneven.